ArticleUrolithiasis2025
Development and validation of an explainable machine learning model for predicting sepsis risk following flexible ureteroscopic lithotripsy.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Establishment and validation of a predictive scoring system for titanium clip retention at six months after endoscopic submucosal dissection for gastric lesions.Scientific reports · 2026Article
- Comment on "Clinical management implications from 33,579 urinary stones: novel patterns in composition, comorbidities, seasonal variation, and machine learning-based urosepsis prediction".International journal of surgery (London, England) · 2026Article
- Comment on: development and validation of an explainable machine learning model for predicting sepsis risk following flexible ureteroscopic lithotripsy.Urolithiasis · 2026Article
- Commentary on "Development and validation of an explainable machine learning model for predicting sepsis risk following flexible ureteroscopic lithotripsy".Urolithiasis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sepsis is a severe complication of flexible ureteroscopic lithotripsy (fURL), a widely used treatment for kidney stones. This study aimed to develop and validate a predictive model based on machine learning (ML) for assessing the risk of sepsis following fURL while enhancing its interpretability through Shapley Additive Explanations (SHAP). This retrospective study in China was conducted to develop and validate a prediction model for sepsis following fURL. The derivation cohort comprised 1,386 patients treated between 2019 and July 2024 divided into training and internal validation subsets. External validation was performed on a cohort of 604 patients treated between 2019 and 2023 at a collaborating center. Sepsis was diagnosed according to Sepsis-3.0 consensus guidelines. Fifteen machine learning algorithms were employed to construct predictive models, and their performance was meticulously evaluated using metrics such as the area under the receiver operating characteristic curve (AUC). To enhance model interpretability, the Shapley Additive Explanations (SHAP) method was applied to assess and rank the importance of individual features. The Extra Trees (ET) model incorporating eight key features demonstrated the best discriminative ability, with an AUC of 0.90. It accurately predicted sepsis in both internal (AUC = 0.87) and external validation (AUC = 0.81). In this study, we developed an Extra Trees (ET) machine learning model to predict sepsis risk following fURL, which demonstrated high accuracy in predicting sepsis in both the internal and external validation cohorts. This model, equipped with SHAP-driven interpretability and deployed as an accessible web application, has the potential to serve as a clinical tool for patient risk stratification following fURL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.